Another study suggests that EA may be considered as a new insulin sensitizer, which could improve insulin sensitivity and T2DM through various mechanisms, such as weight loss, anti-inflammatory, and the improvement of lipid metabolism and adipokines as well (Firouzjaei et al., 2016). This evidence concerns the gene INS and type 2 diabetes mellitus.